Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Next Generation Cancer Diagnostics market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Next Generation Cancer Diagnostics market. Detailed analysis of key players, along with key growth strategies adopted by Next Generation Cancer Diagnostics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Opko Health
Sysmex Corporation
Qiagen
Novartis AG
Illumina
Almac Group
Myriad Genetics
Genomic Health
Thermo Fisher Scientific
PerkinElmer
Janssen Global Services
F Hoffmann-La Roche Ltd
Hologic
Cepheid
Agilent Technologies
Abbott
GE Healthcare
Koninklijke Philips NV
By Type:
Next Generation Sequencing
qPCR & Multiplexing
DNA Microarrays
Others
By End-User:
Hospitals
Clinics
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Next Generation Cancer Diagnostics Market
-
1.3 Market Segment by Type
-
1.3.1 USA Next Generation Cancer Diagnostics Market Size and Growth Rate of Next Generation Sequencing from 2016 to 2027
-
1.3.2 USA Next Generation Cancer Diagnostics Market Size and Growth Rate of qPCR & Multiplexing from 2016 to 2027
-
1.3.3 USA Next Generation Cancer Diagnostics Market Size and Growth Rate of DNA Microarrays from 2016 to 2027
-
1.3.4 USA Next Generation Cancer Diagnostics Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Next Generation Cancer Diagnostics Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 USA Next Generation Cancer Diagnostics Market Size and Growth Rate of Clinics from 2016 to 2027
-
1.4.3 USA Next Generation Cancer Diagnostics Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Next Generation Cancer Diagnostics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Next Generation Cancer Diagnostics by Major Types
-
3.4.1 Market Size and Growth Rate of Next Generation Sequencing
-
3.4.2 Market Size and Growth Rate of qPCR & Multiplexing
-
3.4.3 Market Size and Growth Rate of DNA Microarrays
-
3.4.4 Market Size and Growth Rate of Others
4 Segmentation of Next Generation Cancer Diagnostics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Next Generation Cancer Diagnostics by Major End-Users
-
4.4.1 Market Size and Growth Rate of Next Generation Cancer Diagnostics in Hospitals
-
4.4.2 Market Size and Growth Rate of Next Generation Cancer Diagnostics in Clinics
-
4.4.3 Market Size and Growth Rate of Next Generation Cancer Diagnostics in Others
5 Market Analysis by Regions
-
5.1 USA Next Generation Cancer Diagnostics Production Analysis by Regions
-
5.2 USA Next Generation Cancer Diagnostics Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Next Generation Cancer Diagnostics Landscape Analysis
-
6.1 West USA Next Generation Cancer Diagnostics Landscape Analysis by Major Types
-
6.2 West USA Next Generation Cancer Diagnostics Landscape Analysis by Major End-Users
7 South USA Next Generation Cancer Diagnostics Landscape Analysis
-
7.1 South USA Next Generation Cancer Diagnostics Landscape Analysis by Major Types
-
7.2 South USA Next Generation Cancer Diagnostics Landscape Analysis by Major End-Users
8 Middle West USA Next Generation Cancer Diagnostics Landscape Analysis
-
8.1 Middle West USA Next Generation Cancer Diagnostics Landscape Analysis by Major Types
-
8.2 Middle West USA Next Generation Cancer Diagnostics Landscape Analysis by Major End-Users
9 Northeast USA Next Generation Cancer Diagnostics Landscape Analysis
-
9.1 Northeast USA Next Generation Cancer Diagnostics Landscape Analysis by Major Types
-
9.2 Northeast USA Next Generation Cancer Diagnostics Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Opko Health
-
10.1.1 Opko Health Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Sysmex Corporation
-
10.2.1 Sysmex Corporation Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Qiagen
-
10.3.1 Qiagen Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Novartis AG
-
10.4.1 Novartis AG Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Illumina
-
10.5.1 Illumina Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Almac Group
-
10.6.1 Almac Group Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Myriad Genetics
-
10.7.1 Myriad Genetics Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Genomic Health
-
10.8.1 Genomic Health Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Thermo Fisher Scientific
-
10.9.1 Thermo Fisher Scientific Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 PerkinElmer
-
10.10.1 PerkinElmer Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Janssen Global Services
-
10.11.1 Janssen Global Services Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 F Hoffmann-La Roche Ltd
-
10.12.1 F Hoffmann-La Roche Ltd Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
-
10.13 Hologic
-
10.13.1 Hologic Company Profile and Recent Development
-
10.13.2 Market Performance
-
10.13.3 Product and Service Introduction
-
10.14 Cepheid
-
10.14.1 Cepheid Company Profile and Recent Development
-
10.14.2 Market Performance
-
10.14.3 Product and Service Introduction
-
10.15 Agilent Technologies
-
10.15.1 Agilent Technologies Company Profile and Recent Development
-
10.15.2 Market Performance
-
10.15.3 Product and Service Introduction
-
10.16 Abbott
-
10.16.1 Abbott Company Profile and Recent Development
-
10.16.2 Market Performance
-
10.16.3 Product and Service Introduction
-
10.17 GE Healthcare
-
10.17.1 GE Healthcare Company Profile and Recent Development
-
10.17.2 Market Performance
-
10.17.3 Product and Service Introduction
-
10.18 Koninklijke Philips NV
-
10.18.1 Koninklijke Philips NV Company Profile and Recent Development
-
10.18.2 Market Performance
-
10.18.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Next Generation Cancer Diagnostics Market Size and Growth Rate of Next Generation Sequencing from 2016 to 2027
-
Figure USA Next Generation Cancer Diagnostics Market Size and Growth Rate of qPCR & Multiplexing from 2016 to 2027
-
Figure USA Next Generation Cancer Diagnostics Market Size and Growth Rate of DNA Microarrays from 2016 to 2027
-
Figure USA Next Generation Cancer Diagnostics Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Next Generation Cancer Diagnostics Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure USA Next Generation Cancer Diagnostics Market Size and Growth Rate of Clinics from 2016 to 2027
-
Figure USA Next Generation Cancer Diagnostics Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Next Generation Cancer Diagnostics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Next Generation Cancer Diagnostics
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Next Generation Cancer Diagnostics by Different Types from 2016 to 2027
-
Table Consumption Share of Next Generation Cancer Diagnostics by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Next Generation Sequencing
-
Figure Market Size and Growth Rate of qPCR & Multiplexing
-
Figure Market Size and Growth Rate of DNA Microarrays
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Next Generation Cancer Diagnostics by Different End-Users from 2016 to 2027
-
Table Consumption Share of Next Generation Cancer Diagnostics by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Clinics
-
Figure Market Size and Growth Rate of Others
-
Table USA Next Generation Cancer Diagnostics Production by Regions
-
Table USA Next Generation Cancer Diagnostics Production Share by Regions
-
Figure USA Next Generation Cancer Diagnostics Production Share by Regions in 2016
-
Figure USA Next Generation Cancer Diagnostics Production Share by Regions in 2021
-
Figure USA Next Generation Cancer Diagnostics Production Share by Regions in 2027
-
Table USA Next Generation Cancer Diagnostics Consumption by Regions
-
Table USA Next Generation Cancer Diagnostics Consumption Share by Regions
-
Figure USA Next Generation Cancer Diagnostics Consumption Share by Regions in 2016
-
Figure USA Next Generation Cancer Diagnostics Consumption Share by Regions in 2021
-
Figure USA Next Generation Cancer Diagnostics Consumption Share by Regions in 2027
-
Table West USA Next Generation Cancer Diagnostics Consumption by Types from 2016 to 2027
-
Table West USA Next Generation Cancer Diagnostics Consumption Share by Types from 2016 to 2027
-
Figure West USA Next Generation Cancer Diagnostics Consumption Share by Types in 2016
-
Figure West USA Next Generation Cancer Diagnostics Consumption Share by Types in 2021
-
Figure West USA Next Generation Cancer Diagnostics Consumption Share by Types in 2027
-
Table West USA Next Generation Cancer Diagnostics Consumption by End-Users from 2016 to 2027
-
Table West USA Next Generation Cancer Diagnostics Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Next Generation Cancer Diagnostics Consumption Share by End-Users in 2016
-
Figure West USA Next Generation Cancer Diagnostics Consumption Share by End-Users in 2021
-
Figure West USA Next Generation Cancer Diagnostics Consumption Share by End-Users in 2027
-
Table South USA Next Generation Cancer Diagnostics Consumption by Types from 2016 to 2027
-
Table South USA Next Generation Cancer Diagnostics Consumption Share by Types from 2016 to 2027
-
Figure South USA Next Generation Cancer Diagnostics Consumption Share by Types in 2016
-
Figure South USA Next Generation Cancer Diagnostics Consumption Share by Types in 2021
-
Figure South USA Next Generation Cancer Diagnostics Consumption Share by Types in 2027
-
Table South USA Next Generation Cancer Diagnostics Consumption by End-Users from 2016 to 2027
-
Table South USA Next Generation Cancer Diagnostics Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Next Generation Cancer Diagnostics Consumption Share by End-Users in 2016
-
Figure South USA Next Generation Cancer Diagnostics Consumption Share by End-Users in 2021
-
Figure South USA Next Generation Cancer Diagnostics Consumption Share by End-Users in 2027
-
Table Middle West USA Next Generation Cancer Diagnostics Consumption by Types from 2016 to 2027
-
Table Middle West USA Next Generation Cancer Diagnostics Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Next Generation Cancer Diagnostics Consumption Share by Types in 2016
-
Figure Middle West USA Next Generation Cancer Diagnostics Consumption Share by Types in 2021
-
Figure Middle West USA Next Generation Cancer Diagnostics Consumption Share by Types in 2027
-
Table Middle West USA Next Generation Cancer Diagnostics Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Next Generation Cancer Diagnostics Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Next Generation Cancer Diagnostics Consumption Share by End-Users in 2016
-
Figure Middle West USA Next Generation Cancer Diagnostics Consumption Share by End-Users in 2021
-
Figure Middle West USA Next Generation Cancer Diagnostics Consumption Share by End-Users in 2027
-
Table Northeast USA Next Generation Cancer Diagnostics Consumption by Types from 2016 to 2027
-
Table Northeast USA Next Generation Cancer Diagnostics Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Next Generation Cancer Diagnostics Consumption Share by Types in 2016
-
Figure Northeast USA Next Generation Cancer Diagnostics Consumption Share by Types in 2021
-
Figure Northeast USA Next Generation Cancer Diagnostics Consumption Share by Types in 2027
-
Table Northeast USA Next Generation Cancer Diagnostics Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Next Generation Cancer Diagnostics Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Next Generation Cancer Diagnostics Consumption Share by End-Users in 2016
-
Figure Northeast USA Next Generation Cancer Diagnostics Consumption Share by End-Users in 2021
-
Figure Northeast USA Next Generation Cancer Diagnostics Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Opko Health
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Opko Health
-
Figure Sales and Growth Rate Analysis of Opko Health
-
Figure Revenue and Market Share Analysis of Opko Health
-
Table Product and Service Introduction of Opko Health
-
Table Company Profile and Development Status of Sysmex Corporation
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sysmex Corporation
-
Figure Sales and Growth Rate Analysis of Sysmex Corporation
-
Figure Revenue and Market Share Analysis of Sysmex Corporation
-
Table Product and Service Introduction of Sysmex Corporation
-
Table Company Profile and Development Status of Qiagen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Qiagen
-
Figure Sales and Growth Rate Analysis of Qiagen
-
Figure Revenue and Market Share Analysis of Qiagen
-
Table Product and Service Introduction of Qiagen
-
Table Company Profile and Development Status of Novartis AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG
-
Figure Sales and Growth Rate Analysis of Novartis AG
-
Figure Revenue and Market Share Analysis of Novartis AG
-
Table Product and Service Introduction of Novartis AG
-
Table Company Profile and Development Status of Illumina
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Illumina
-
Figure Sales and Growth Rate Analysis of Illumina
-
Figure Revenue and Market Share Analysis of Illumina
-
Table Product and Service Introduction of Illumina
-
Table Company Profile and Development Status of Almac Group
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Almac Group
-
Figure Sales and Growth Rate Analysis of Almac Group
-
Figure Revenue and Market Share Analysis of Almac Group
-
Table Product and Service Introduction of Almac Group
-
Table Company Profile and Development Status of Myriad Genetics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Myriad Genetics
-
Figure Sales and Growth Rate Analysis of Myriad Genetics
-
Figure Revenue and Market Share Analysis of Myriad Genetics
-
Table Product and Service Introduction of Myriad Genetics
-
Table Company Profile and Development Status of Genomic Health
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genomic Health
-
Figure Sales and Growth Rate Analysis of Genomic Health
-
Figure Revenue and Market Share Analysis of Genomic Health
-
Table Product and Service Introduction of Genomic Health
-
Table Company Profile and Development Status of Thermo Fisher Scientific
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thermo Fisher Scientific
-
Figure Sales and Growth Rate Analysis of Thermo Fisher Scientific
-
Figure Revenue and Market Share Analysis of Thermo Fisher Scientific
-
Table Product and Service Introduction of Thermo Fisher Scientific
-
Table Company Profile and Development Status of PerkinElmer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of PerkinElmer
-
Figure Sales and Growth Rate Analysis of PerkinElmer
-
Figure Revenue and Market Share Analysis of PerkinElmer
-
Table Product and Service Introduction of PerkinElmer
-
Table Company Profile and Development Status of Janssen Global Services
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen Global Services
-
Figure Sales and Growth Rate Analysis of Janssen Global Services
-
Figure Revenue and Market Share Analysis of Janssen Global Services
-
Table Product and Service Introduction of Janssen Global Services
-
Table Company Profile and Development Status of F Hoffmann-La Roche Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche Ltd
-
Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche Ltd
-
Figure Revenue and Market Share Analysis of F Hoffmann-La Roche Ltd
-
Table Product and Service Introduction of F Hoffmann-La Roche Ltd
-
Table Company Profile and Development Status of Hologic
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hologic
-
Figure Sales and Growth Rate Analysis of Hologic
-
Figure Revenue and Market Share Analysis of Hologic
-
Table Product and Service Introduction of Hologic
-
Table Company Profile and Development Status of Cepheid
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cepheid
-
Figure Sales and Growth Rate Analysis of Cepheid
-
Figure Revenue and Market Share Analysis of Cepheid
-
Table Product and Service Introduction of Cepheid
-
Table Company Profile and Development Status of Agilent Technologies
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agilent Technologies
-
Figure Sales and Growth Rate Analysis of Agilent Technologies
-
Figure Revenue and Market Share Analysis of Agilent Technologies
-
Table Product and Service Introduction of Agilent Technologies
-
Table Company Profile and Development Status of Abbott
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott
-
Figure Sales and Growth Rate Analysis of Abbott
-
Figure Revenue and Market Share Analysis of Abbott
-
Table Product and Service Introduction of Abbott
-
Table Company Profile and Development Status of GE Healthcare
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GE Healthcare
-
Figure Sales and Growth Rate Analysis of GE Healthcare
-
Figure Revenue and Market Share Analysis of GE Healthcare
-
Table Product and Service Introduction of GE Healthcare
-
Table Company Profile and Development Status of Koninklijke Philips NV
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Koninklijke Philips NV
-
Figure Sales and Growth Rate Analysis of Koninklijke Philips NV
-
Figure Revenue and Market Share Analysis of Koninklijke Philips NV
-
Table Product and Service Introduction of Koninklijke Philips NV
-
